AlbertT.QuieryJr.MDMSc FACP
Hematology • Asheville, NCBlood Banking & Transfusion Medicine, Clotting Disorder, Hematologic Oncology
Medical Director
Dr. Quiery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
21 Hospital Dr
4th Floor
Asheville, NC 28801Phone+1 828-253-4262
Education & Training
Creighton University, School of MedicineMaster of Science, Health Care Ethics, 2011 - 2014
Stony Brook MedicineFellowship, Blood Banking/Transfusion Medicine, 1990 - 1992
Duke University HospitalFellowship, Hematology and Medical Oncology, 1988 - 1989- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1984 - 1988
Albert Einstein College of MedicineClass of 1984- Stony Brook UniversityB.S, Biochemistry, Phi Beta Kappa, 1976 - 1980
Certifications & Licensure
TN State Medical License 2023 - 2026
NC State Medical License 2019 - 2025
MI State Medical License 2014 - 2021
PA State Medical License 1991 - 2014
NY State Medical License 1985 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- Alpha Omega Alpha Stony Brook University School of Medicine, 1987
- Phi Beta Kappa SUNY Stony Brook, 1980
- Fellow (FACP) American College of Physicians, 2005
Publications & Presentations
PubMed
- 69 citationsSafety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.Daniel J DeAngelo, Deepti H Radia, Tracy I George, William A Robinson, Albert T Quiery
Nature Medicine. 2021-12-01 - 3 citationsMorphoproteomic expression of H-ras (p21ras) correlates with serum monoclonal immunoglobulin reduction in multiple myeloma patients following pamidronate treatment.Ping L. Zhang, Albert T. Quiery, Thomas M. Blasick, Robert E. Brown
Annals of Clinical and Laboratory Science. 2007-12-21 - 183 citationsRuxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.Asra Ahmed, Samuel A. Merrill, Fares Alsawah, Paula L. Bockenstedt, Erica L. Campagnaro
The Lancet. Haematology. 2019-09-16
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
